MariMed (MRMD) Projected to Post Quarterly Earnings on Wednesday

MariMed (OTCMKTS:MRMD) is expected to be announcing its Q2 2025 earnings results after the market closes on Wednesday, August 6th. Analysts expect the company to announce earnings of ($0.01) per share and revenue of $40.80 million for the quarter.

MariMed (OTCMKTS:MRMD) last announced its earnings results on Wednesday, May 7th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The firm had revenue of $37.96 million for the quarter, compared to the consensus estimate of $38.33 million. MariMed had a negative net margin of 10.33% and a negative return on equity of 10.21%.

MariMed Stock Performance

Shares of MRMD opened at $0.10 on Tuesday. The company has a market capitalization of $38.73 million, a PE ratio of -3.31 and a beta of 3.02. MariMed has a one year low of $0.07 and a one year high of $0.29. The company has a debt-to-equity ratio of 1.21, a current ratio of 1.05 and a quick ratio of 0.37. The company’s fifty day moving average price is $0.09 and its 200 day moving average price is $0.10.

About MariMed

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.